Our Chairman Tony de Fougerolles discusses innate immune rejuvenation

Alex Blyth, CEO
May 28
1 min read

Updated: May 29

Chairman of LIfT BioSciences, to explore the concept of innate immune rejuvenation – a central pillar of our approach to overcoming treatment resistance in solid tumours.

Recent Posts

See All

LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities

LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for Cell and Gene Therapy

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

Comments

Stay up-to-date with our progress and latest news